Great Point Partners has raised $75 million from 60 investors toward a second private equity fund, against a $200 million goal.
Since Dr. Jeffrey Jay co-founded Greenwich-based Great Point and its $156 million debut fund a decade ago, the firm has focused on investments in the health and life sciences sector, with its portfolio having included Biodel Inc., a Danbury-based developer of drugs to treat diabetes.